Craft

LIFNano Therapeutics

Total Funding

$1.2 M

LIFNano Therapeutics Summary

Company Summary

Overview
LIFNano Therapeutics (also known as LIFNano Rx) is a nanobiomedicine company providing treatments for multiple sclerosis and other neurodegenerative diseases. It is focused on targeted delivery of the biologic, Leukaemia Inhibitory Factor (LIF), that helps to promote tissue repair and suppress disease-linked inflammation.
Type
Private
Status
Active
Founded
2013
Website
https://www.lifnano.com/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Andrew Wood

    Andrew Wood, Chief Financial Officer

    • Su Metcalfe

      Su Metcalfe, Chief Executive Officer, Founder, and President

      Footer menu